These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 18698298

  • 1. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
    Gupta A, Muecke JS.
    Retina; 2008; 28(7):964-8. PubMed ID: 18698298
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
    Mason JO, Albert MA, Persaud TO, Vail RS.
    Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
    Ziemssen F, Voelker M, Altpeter E, Bartz-Schmidt KU, Gelisken F.
    Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
    [No Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Aug; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 5. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
    Kaplan RI, Chaugule SS, Finger PT.
    Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
    Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU.
    Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
    [Abstract] [Full Text] [Related]

  • 8. Intravitreous ranibizumab (lucentis) for radiation maculopathy.
    Finger PT, Chin KJ.
    Arch Ophthalmol; 2010 Feb; 128(2):249-52. PubMed ID: 20142553
    [No Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
    Shah SU, Shields CL, Bianciotto CG, Iturralde J, Al-Dahmash SA, Say EAT, Badal J, Mashayekhi A, Shields JA.
    Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Jan; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 11. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA, Bell DJ, Woods P, Pollard J, Boord T, Herro A, Porbandarwalla S.
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [Abstract] [Full Text] [Related]

  • 12. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.
    Finger PT, Chin K.
    Arch Ophthalmol; 2007 Jun; 125(6):751-6. PubMed ID: 17562985
    [Abstract] [Full Text] [Related]

  • 13. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.
    Retina; 2006 Jun; 26(5):495-511. PubMed ID: 16770255
    [Abstract] [Full Text] [Related]

  • 14. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
    Caminal JM, Flores-Moreno I, Arias L, Gutiérrez C, Piulats JM, Català J, Rubio MJ, Cobos E, García P, Pera J, Giralt J, Arruga J.
    Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.
    Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.
    Retina; 2007 Sep; 27(4):419-25. PubMed ID: 17420692
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.
    Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM, Fisher YL, Cooney MJ, Yannuzzi LA.
    Retina; 2007 Sep; 27(4):451-7. PubMed ID: 17420697
    [Abstract] [Full Text] [Related]

  • 17. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.
    Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P.
    J Cataract Refract Surg; 2008 Jan; 34(1):70-5. PubMed ID: 18165084
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
    Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A.
    Retina; 2007 Oct; 27(8):1004-12. PubMed ID: 18040236
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.
    Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J, Pan-American Collaborative Retina Study Group (PACORES).
    Retina; 2008 Feb; 28(2):212-9. PubMed ID: 18301025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.